canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat gouty arthritis by suppressing inflammation results of a randomized, dose-ranging study英文论文.pdfVIP

  • 1
  • 0
  • 约7.85万字
  • 约 13页
  • 2017-09-17 发布于上海
  • 举报

canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat gouty arthritis by suppressing inflammation results of a randomized, dose-ranging study英文论文.pdf

canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat gouty arthritis by suppressing inflammation results of a randomized, dose-ranging study英文论文

Schlesinger et al. Arthritis Research Therapy 2011, 13:R53 /content/13/2/R53 RESEARCH ARTICLE Open Access Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study 1* 2 3 4 5 5 Naomi Schlesinger , Marc

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档